Corcept Therapeutics Inc
CORT
Revenue
182.55M
▲18.75M▲11.45%
3 Months ChangeAssets
784.26M
▲69.70M▲9.75%
3 Months ChangeLiabilities
145.42M
▲27.11M▲22.91%
3 Months ChangeFree Cash Flow
25.96M
▼-9.28M▼-26.33%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 10-Q
ID: 0001628280-24-044322
2024-10-30
Form 8-K
ID: 0001628280-24-044318
2024-07-29
Form 10-Q
ID: 0001628280-24-033284
2024-07-29
Form 8-K
ID: 0001628280-24-033281
2024-05-23
Form 8-K
ID: 0001628280-24-024936
2024-05-01
Form 10-Q
ID: 0001628280-24-019610
2024-05-01
Form 8-K
ID: 0001628280-24-019607
2024-04-17
Form 8-K
ID: 0001193125-24-098492
2024-02-15
Form 8-K
ID: 0001628280-24-005048
2024-01-08
Form 8-K
ID: 0001193125-24-003933